Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery
In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed
Tag: Antibody
Antibody conjugated cyclodextrin for tumor drug delivery
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with